跳至主要内容
临床试验/ISRCTN13334317
ISRCTN13334317进行中(未招募)3 期

Phase 3 evaluation of an innovative simple molecular test for the diagnosis of malaria in different endemic and health settings in sub-Saharan Africa

Academic Medical Center0 个研究点目标入组 4,541 人开始时间: 2022年2月22日最近更新:
适应症

试验速览

阶段
3 期
状态
进行中(未招募)
发起方
入组人数
4,541

研究概览

简要总结

2022 Protocol article in https://pubmed.ncbi.nlm.nih.gov/36048775/ (added 02/09/2022)

研究设计

研究类型
Observational

入排标准

性别
All

入选标准

  • In Sudan, Ethiopia, Burkina Faso and Kenya, the study will include patients who fulfil the following inclusion criteria:
  • 1. Potential participant (patients with clinical suspicion of malaria) of all ages presenting at the health facility;
  • 2. Coming from the health centre catchment area;
  • 3. Informed consent from patient or of parents/guardians (in case of minors).
  • In Namibia, the study will include persons who fulfil the following criteria:
  • 1. Be a resident of one of the selected households or have slept the night before in this household.
  • 2. Informed consent from potential participants (individually).

排除标准

  • Not meeting the above inclusion criteria, depending on study site.

研究者

发起方
Academic Medical Center

相似试验